BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 28958389)

  • 21. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
    Yan N; Xu L; Wu X; Zhang L; Fei X; Cao Y; Zhang F
    Exp Cell Res; 2017 Oct; 359(2):405-414. PubMed ID: 28823831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX.
    Arcipowski KM; Martinez CA; Ntziachristos P
    Curr Opin Genet Dev; 2016 Feb; 36():59-67. PubMed ID: 27151432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors.
    Dalvi MP; Wang L; Zhong R; Kollipara RK; Park H; Bayo J; Yenerall P; Zhou Y; Timmons BC; Rodriguez-Canales J; Behrens C; Mino B; Villalobos P; Parra ER; Suraokar M; Pataer A; Swisher SG; Kalhor N; Bhanu NV; Garcia BA; Heymach JV; Coombes K; Xie Y; Girard L; Gazdar AF; Kittler R; Wistuba II; Minna JD; Martinez ED
    Cell Rep; 2017 May; 19(8):1669-1684. PubMed ID: 28538184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based design and discovery of potent and selective KDM5 inhibitors.
    Nie Z; Shi L; Lai C; O'Connell SM; Xu J; Stansfield RK; Hosfield DJ; Veal JM; Stafford JA
    Bioorg Med Chem Lett; 2018 May; 28(9):1490-1494. PubMed ID: 29627262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the histone demethylase KDM4A in cancer.
    Guerra-Calderas L; González-Barrios R; Herrera LA; Cantú de León D; Soto-Reyes E
    Cancer Genet; 2015 May; 208(5):215-24. PubMed ID: 25633974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Jumonji gene family in Crassostrea gigas suggests evolutionary conservation of Jmj-C histone demethylases orthologues in the oyster gametogenesis and development.
    Fellous A; Favrel P; Guo X; Riviere G
    Gene; 2014 Mar; 538(1):164-75. PubMed ID: 24406622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
    Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
    Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells.
    Catchpole S; Spencer-Dene B; Hall D; Santangelo S; Rosewell I; Guenatri M; Beatson R; Scibetta AG; Burchell JM; Taylor-Papadimitriou J
    Int J Oncol; 2011 May; 38(5):1267-77. PubMed ID: 21369698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting epigenetic regulators to overcome drug resistance in cancers.
    Wang N; Ma T; Yu B
    Signal Transduct Target Ther; 2023 Feb; 8(1):69. PubMed ID: 36797239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting histone demethylase KDM5B for cancer treatment.
    Fu YD; Huang MJ; Guo JW; You YZ; Liu HM; Huang LH; Yu B
    Eur J Med Chem; 2020 Dec; 208():112760. PubMed ID: 32883639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives.
    Westaway SM; Preston AG; Barker MD; Brown F; Brown JA; Campbell M; Chung CW; Drewes G; Eagle R; Garton N; Gordon L; Haslam C; Hayhow TG; Humphreys PG; Joberty G; Katso R; Kruidenier L; Leveridge M; Pemberton M; Rioja I; Seal GA; Shipley T; Singh O; Suckling CJ; Taylor J; Thomas P; Wilson DM; Lee K; Prinjha RK
    J Med Chem; 2016 Feb; 59(4):1370-87. PubMed ID: 26771203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone demethylase JARID1B promotes cell proliferation but is downregulated by N-Myc oncoprotein.
    Zhang L; Sokolowski N; Atmadibrata B; Liu T
    Oncol Rep; 2014 Apr; 31(4):1935-9. PubMed ID: 24481781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unravelling KDM4 histone demethylase inhibitors for cancer therapy.
    Baby S; Gurukkala Valapil D; Shankaraiah N
    Drug Discov Today; 2021 Aug; 26(8):1841-1856. PubMed ID: 34051367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth.
    Wang L; Chang J; Varghese D; Dellinger M; Kumar S; Best AM; Ruiz J; Bruick R; Peña-Llopis S; Xu J; Babinski DJ; Frantz DE; Brekken RA; Quinn AM; Simeonov A; Easmon J; Martinez ED
    Nat Commun; 2013; 4():2035. PubMed ID: 23792809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance.
    Liau BB; Sievers C; Donohue LK; Gillespie SM; Flavahan WA; Miller TE; Venteicher AS; Hebert CH; Carey CD; Rodig SJ; Shareef SJ; Najm FJ; van Galen P; Wakimoto H; Cahill DP; Rich JN; Aster JC; Suvà ML; Patel AP; Bernstein BE
    Cell Stem Cell; 2017 Feb; 20(2):233-246.e7. PubMed ID: 27989769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibiting the Jumonji family: a potential new clinical approach to targeting aberrant epigenetic mechanisms.
    Martinez ED; Gazdar AF
    Epigenomics; 2016 Mar; 8(3):313-6. PubMed ID: 26918824
    [No Abstract]   [Full Text] [Related]  

  • 37. The Jumonji family: past, present and future of histone demethylases in cancer.
    Franci G; Ciotta A; Altucci L
    Biomol Concepts; 2014 Jun; 5(3):209-24. PubMed ID: 25372754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3.
    Christensen J; Agger K; Cloos PA; Pasini D; Rose S; Sennels L; Rappsilber J; Hansen KH; Salcini AE; Helin K
    Cell; 2007 Mar; 128(6):1063-76. PubMed ID: 17320161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic.
    Zhang SM; Cao J; Yan Q
    Adv Exp Med Biol; 2023; 1433():113-137. PubMed ID: 37751138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural analysis of human KDM5B guides histone demethylase inhibitor development.
    Johansson C; Velupillai S; Tumber A; Szykowska A; Hookway ES; Nowak RP; Strain-Damerell C; Gileadi C; Philpott M; Burgess-Brown N; Wu N; Kopec J; Nuzzi A; Steuber H; Egner U; Badock V; Munro S; LaThangue NB; Westaway S; Brown J; Athanasou N; Prinjha R; Brennan PE; Oppermann U
    Nat Chem Biol; 2016 Jul; 12(7):539-45. PubMed ID: 27214403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.